Stay updated on MGD013 and Brivanib in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.

Latest updates to the MGD013 and Brivanib in Liver Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing 'HHS Vulnerability Disclosure' in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedA new revision label v3.3.2 is added as the latest entry in the study record history, replacing v3.2.0. This is a record-keeping update that does not affect the study content.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the government funding/operating status notice from the page. This change does not affect the study data or the record history.SummaryDifference0.7%

- Check65 days agoChange DetectedVersion 6 (2024-06-26) was added, showing updates to Study Status, Study Design, Outcome Measures, and Adverse Events. It includes a note that the Quality Control Review Has Not Concluded and indicates Returned: 2024-06-24.SummaryDifference0.1%

- Check93 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

- Check100 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. No other page content appears affected.SummaryDifference0.3%

Stay in the know with updates to MGD013 and Brivanib in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.